ARCHIVES

FDA to refer false statements by regulated companies to SEC.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

NCAB Approves Plan for National Black Leadership Initiative

October 16, 1987

George Sledge Jr. Named Oncology Chief at Stanford University

October 12, 2012

NIH Seeks Comment On Reorg Plan For Oncology Study Sections

April 5, 2002

“Leadership Vacuum: At NCI Allows NIH To Look At Reorganization, Varmus Says

November 4, 1994

Some NCI Responses To CCOP Letters Of Intent Missing; NCAB Debates Pediatric Issues

October 8, 1982

UT System Chancellor to Travel to MD Anderson After Faculty Senate Survey Finds Plunging Morale

September 6, 2013